TY  - JOUR
A1  - Kraft, Peter
A1  - Benz, Peter Michael
A1  - Austinat, Madeleine
A1  - Brede, Marc Elmar
A1  - Schuh, Kai
A1  - Walter, Ulrich
A1  - Stoll, Guido
A1  - Kleinschnitz, Christoph
T1  - Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice
N2  - Background: Stroke-induced brain edema formation is a frequent cause of secondary infarct growth and deterioration of neurological function. The molecular mechanisms underlying edema formation after stroke are largely unknown. Vasodilator-stimulated phosphoprotein (VASP) is an important regulator of actin dynamics and stabilizes endothelial barriers through interaction with cell-cell contacts and focal adhesion sites. Hypoxia has been shown to foster vascular leakage by downregulation of VASP in vitro but the significance of VASP for regulating vascular permeability in the hypoxic brain in vivo awaits clarification. Methodology/Principal Findings: Focal cerebral ischemia was induced in Vasp2/2 mice and wild-type (WT) littermates by transient middle cerebral artery occlusion (tMCAO). Evan’s Blue tracer was applied to visualize the extent of blood-brainbarrier (BBB) damage. Brain edema formation and infarct volumes were calculated from 2,3,5-triphenyltetrazolium chloride (TTC)-stained brain slices. Both mouse groups were carefully controlled for anatomical and physiological parameters relevant for edema formation and stroke outcome. BBB damage (p,0.05) and edema volumes (1.7 mm360.5 mm3 versus 0.8 mm360.4 mm3; p,0.0001) were significantly enhanced in Vasp2/2 mice compared to controls on day 1 after tMCAO. This was accompanied by a significant increase in infarct size (56.1 mm3617.3 mm3 versus 39.3 mm3610.7 mm3, respectively; p,0.01) and a non significant trend (p.0.05) towards worse neurological outcomes. Conclusion: Our study identifies VASP as critical regulator of BBB maintenance during acute ischemic stroke. Therapeutic modulation of VASP or VASP-dependent signalling pathways could become a novel strategy to combat excessive edema formation in ischemic brain damage.
KW  - Vasodilatator-stimuliertes Phosphoprotein
KW  - Vasodilator-Stimulated Phosphoprotein
Y1  - 2010
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-68522
ER  - 
TY  - THES
A1  - Brede, Marc
T1  - Kardiovaskuläre Phänotypisierung von Angiotensin II AT2-Rezeptor- und adrenergen Rezeptor-"Knockout"-Mäusen
T1  - Cardiovascular characterization of Angiotensin II AT2-receptor- and adrenergic receptor-knockout-mice
N2  - Die Deletion des AT2-Rezeptors (AT2-KO) führt zu erhöhter Blutdruckempfindlichkeit und vaskulärer Hypertrophie durch Aktivitätszunahhme der P70S6-Kinase. Die Vasodilatation von Blutgefäßen wird maßgeblich durch beta1-adrenerge Rezeptoren vermittelt. Die Deletion von alpha2-adrenergen Rezeptoren (alpha2-KO) führt zur Entwicklung einer Herzinsuffizienz nach Aortenstenose. Der Mortalitätanstieg ist mit erhöhten Plasmanoradrenalin-Spiegeln (a2A-KO), bzw. Plasmaadrenalin-Spiegeln (a2C-KO) assoziiert.
N2  - The deletion of AT2-receptors causes increased blood-pressure sensitivity and vascular hypertrophy by increased P70S6-Kinase activity. Vasodilation is mainly mediated by beta1-adrenoceptors. The deletion of alpha2-adrenoceptors leads to heart failure after aortic banding. The increased mortality is associated with elevated plasma levels of norepinephrine (a2A-KO) or epinephrine (a2C-KO).
KW  - transgen
KW  - Maus
KW  - Angiotensin
KW  - Rezeptor
KW  - adrenerg
KW  - Katecholamine
KW  - Blutgefäß
KW  - Hypertrophie
KW  - Herzinsuffizienz
KW  - Nebenniere
KW  - Angiotensin
KW  - receptor
KW  - adrenergic
KW  - catecholamines
KW  - vessel
KW  - hypertrophy
KW  - heart failure
KW  - adrenal gland
Y1  - 2001
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-1179726
ER  -